Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.700
-0.090 (-5.03%)
At close: Mar 12, 2026, 4:00 PM EDT
1.719
+0.019 (1.09%)
After-hours: Mar 12, 2026, 7:07 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Blood Safety
206.13M180.27M156.37M162.05M130.86M
Blood Safety Growth
14.35%15.29%-3.51%23.83%42.36%
Total
206.13M180.27M156.37M162.05M130.86M
Total Growth
14.35%15.29%-3.51%23.83%42.36%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
124.72M109.26M93.23M101.39M67.50M
United States Growth
14.16%17.19%-8.05%50.21%114.16%
France
21.20M19.69M18.49M19.33M20.89M
France Growth
7.65%6.50%-4.33%-7.47%7.64%
Other Countries
60.21M51.32M44.65M41.33M42.47M
Other Countries Growth
17.32%14.96%8.02%-2.69%3.60%
Total
206.13M180.27M156.37M162.05M130.86M
Total Growth
14.35%15.29%-3.51%23.83%42.36%
Source: S&P Global Market Intelligence.